Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F Tarantilis
Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line for the Management of Rheumatoid Arthritis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pms56 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Without Methotrexate in Rheumatoid Arthritis Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms44 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Abatacept, Tocilizumab and TNF-inhibitors Compared With Rituximab as Second-Line Biologic Drug in Rheumatoid Arthritis
PLoS ONE
Multidisciplinary
Immunotherapy of Tocilizumab for Rheumatoid Arthritis
Journal of Clinical & Cellular Immunology
Cost-Effectiveness of Adalimumab for Rheumatoid Arthritis in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms41 - Cost-Effectiveness Analysis of Tofacitinib in Combination With Methotrexate in the Treatment of Moderate to Severe Rheumatoid Arthritis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost Effectiveness of TNF-αInhibitors in Rheumatoid Arthritis
International Journal of Inflammation
Allergy
Immunology
PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms24 - Cost Minimization Analysis of Third Line Rheumatoid Arthritis Drugs in Ecuador
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
